Fertility and Sterility
Volume 91, Issue 6 , Pages 2432-2436, June 2009

Assessment of day-3 morphology and euploidy for individual chromosomes in embryos that develop to the blastocyst stage

  • Jennifer L. Eaton, M.D.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
    • ,
  • Michele R. Hacker, Sc.D., M.S.P.H.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
    • ,
  • Doria Harris, Ph.D.

      Affiliations

    • Boston IVF, Waltham, Massachusetts
    • ,
  • Kim L. Thornton, M.D.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
    • Boston IVF, Waltham, Massachusetts
    • ,
  • Alan S. Penzias, M.D.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
    • Boston IVF, Waltham, Massachusetts
    • Corresponding Author InformationReprint requests: Alan Penzias, M.D., Boston IVF/Harvard Medical School, 130 Second Avenue, Waltham, MA02451 (FAX: 781-434-6501).

Received 21 November 2007; received in revised form 5 March 2008; accepted 5 March 2008. published online 28 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J.L.E. has nothing to disclose. M.R.H. is a consultant and member of the data safety monitoring board of Bayer Pharmaceuticals. D.H. has spouse with Incept Biosystems. K.L.T. is a consultant for and receives research support from Organon, is a speaker for and receives research support from EMD Serono, and receives research support from Ferring Pharmaceuticals. A.S.P. receives grant support from EMD Serono, Organon, and Ferring Pharmaceuticals, and is on the speakers bureau of Ferring Pharmaceuticals.

 Presented at the American Society for Reproductive Medicine 63rd Annual Meeting, Washington, DC, October 13–17, 2007.

PII: S0015-0282(08)00581-5

doi:10.1016/j.fertnstert.2008.03.008

Fertility and Sterility
Volume 91, Issue 6 , Pages 2432-2436, June 2009

Article Tools